Age-Mediated Transcriptomic Changes in Adult Mouse Substantia Nigra

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Gao, Lin ^a,b   Hidalgo Figueroa, María ^a,b   Escudero, Luis M ^a,b   Díaz Martín, Juan ^a,b   López Barneo, José ^a,b   Pascual, Alberto ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC PARAMETERS; MICROARRAY ANALYSIS; MIDDLE AGED; MOUSE; NONHUMAN; PSYCHOMOTOR PERFORMANCE; SUBSTANTIA NIGRA PARS COMPACTA; TRANSCRIPTIONAL SIGNATURE; TRANSCRIPTOMICS; VENTRAL TEGMENTUM; ANIMAL; C57BL MOUSE; FEMALE; MALE; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; SUBSTANTIA NIGRA;

MUS;

TRANSCRIPTOME;

AGING; ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; SUBSTANTIA NIGRA; TRANSCRIPTOME; VENTRAL TEGMENTAL AREA;

EID: 84876960796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062456     Document Type: Article

References (52)

1. Mattson MP, Magnus T, (2006) Ageing and neuronal vulnerability. Nature Reviews Neuroscience 7: 278-294.
2. Fearnley JM, Lees AJ, (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (Pt 5): 2283-2301.
3. Stark AK, Pakkenberg B, (2004) Histological changes of the dopaminergic nigrostriatal system in aging. Cell and Tissue Research 318: 81-92.
4. Rudow G, O'Brien R, Savonenko AV, Resnick SM, Zonderman AB, et al. (2008) Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol 115: 461-470.
5. Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, et al. (2004) Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Annals of Neurology 56: 532-539.
6. Rollo CD, (2009) Dopamine and aging: intersecting facets. Neurochemical Research 34: 601-629.
7. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, et al. (2007) 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447: 1081-1086.
8. Chan CS, Gertler TS, Surmeier DJ, (2009) Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci 32: 249-256.
9. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, et al. (2010) Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468: 696-700.
10. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, et al. (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62: 218-229.
11. Elstner M, Morris CM, Heim K, Bender A, Mehta D, et al. (2011) Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol 122: 75-86.
12. Villar-Cheda B, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL (2012) Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration. Neurobiology of Aging 33: 204 e201-204 e211.
13. Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, et al. (2004) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A 101: 9843-9848.
14. Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, et al. (1992) Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proceedings of the National Academy of Sciences of the United States of America 89: 7095-7099.
15. Bannon MJ, Whitty CJ, (1997) Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology 48: 969-977.
16. Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH, (2002) Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. Journal of Comparative Neurology 450: 203-214.
17. Himi T, Cao M, Mori N, (1995) Reduced expression of the molecular markers of dopaminergic neuronal atrophy in the aging rat brain. Journals of Gerontology Series A, Biological Sciences and Medical Sciences 50: B193-200.
18. Salvatore MF, Pruett BS, Spann SL, Dempsey C, (2009) Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation. PLoS One 4: e8466.
19. Schuligoi R, Fernandez J, Heavens RP, Sirinathsinghji DJ, (1993) Decreased tyrosine hydroxylase mRNA but not cholecystokinin mRNA in the pars compacta of the substantia nigra and ventral tegmental area of aged rats. Brain Research Molecular Brain Research 19: 333-338.
20. Dickerson JW, Hemmerle AM, Numan S, Lundgren KH, Seroogy KB, (2009) Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats. Neuroscience 163: 482-489.
21. Chen HL, Lein PJ, Wang JY, Gash D, Hoffer BJ, et al. (2003) Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals. Brain Research 994: 81-90.
22. Castel MN, Beaudet A, Laduron PM, (1994) Retrograde axonal transport of neurotensin in rat nigrostriatal dopaminergic neurons. Modulation during ageing and possible physiological role. Biochemical Pharmacology 47: 53-62.
23. Villar-Cheda B, Sousa-Ribeiro D, Rodriguez-Pallares J, Rodriguez-Perez AI, Guerra MJ, et al. (2009) Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism 29: 230-234.
24. Bordner KA, Kitchen RR, Carlyle B, George ED, Mahajan MC, et al. (2011) Parallel declines in cognition, motivation, and locomotion in aging mice: association with immune gene upregulation in the medial prefrontal cortex. Experimental Gerontology 46: 643-659.
25. Fraser HB, Khaitovich P, Plotkin JB, Paabo S, Eisen MB, (2005) Aging and gene expression in the primate brain. PLoS Biology 3: e274.
26. Kedmi M, Orr-Urtreger A, (2011) The effects of aging vs. alpha7 nAChR subunit deficiency on the mouse brain transcriptome: aging beats the deficiency. Age (Dordr) 33: 1-13.
27. Lee CK, Weindruch R, Prolla TA, (2000) Gene-expression profile of the ageing brain in mice. Nat Genet 25: 294-297.
28. Lu T, Pan Y, Kao SY, Li C, Kohane I, et al. (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429: 883-891.
29. Oberdoerffer P, Sinclair DA, (2007) The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol 8: 692-702.
30. Sharman EH, Bondy SC, Sharman KG, Lahiri D, Cotman CW, et al. (2007) Effects of melatonin and age on gene expression in mouse CNS using microarray analysis. Neurochemistry International 50: 336-344.
31. Terao A, Apte-Deshpande A, Dousman L, Morairty S, Eynon BP, et al. (2002) Immune response gene expression increases in the aging murine hippocampus. Journal of Neuroimmunology 132: 99-112.
32. Xu X, Zhan M, Duan W, Prabhu V, Brenneman R, et al. (2007) Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender. Genome Biology 8: R234.
33. Lee CK, Klopp RG, Weindruch R, Prolla TA, (1999) Gene expression profile of aging and its retardation by caloric restriction. Science 285: 1390-1393.
34. Jucker M, Ingram DK, (1997) Murine models of brain aging and age-related neurodegenerative diseases. Behavioural Brain Research 85: 1-26.
35. Pascual A, Hidalgo-Figueroa M, Piruat JI, Pintado CO, Gomez-Diaz R, et al. (2008) Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nature Neuroscience 11: 755-761.
36. Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates: Academic Press-Elsevier.
37. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
38. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
39. Smyth GK (2004) Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Statistical Applications in Genetics and Molecular Biology 3: Article 3.
40. Jeanmougin M, de Reynies A, Marisa L, Paccard C, Nuel G, et al. (2010) Should we abandon the t-test in the analysis of gene expression microarray data: a comparison of variance modeling strategies. PLoS ONE 5: e12336.
41. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
42. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 30: 207-210.
43. Parkinson H, Kapushesky M, Shojatalab M, Abeygunawardena N, Coulson R, et al. (2007) ArrayExpress-a public database of microarray experiments and gene expression profiles. Nucleic Acids Research 35: D747-750.
44. Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, et al. (2008) SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135: 907-918.
45. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, et al. (2008) A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 3: e2264.
46. Perreau VM, Bondy SC, Cotman CW, Sharman KG, Sharman EH, (2007) Melatonin treatment in old mice enables a more youthful response to LPS in the brain. Journal of Neuroimmunology 182: 22-31.
47. Hidalgo-Figueroa M, Bonilla S, Gutierrez F, Pascual A, Lopez-Barneo J, (2012) GDNF Is Predominantly Expressed in the PV+ Neostriatal Interneuronal Ensemble in Normal Mouse and after Injury of the Nigrostriatal Pathway. Journal of Neuroscience 32: 864-872.
48. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, et al. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445: 168-176.
49. Korotkova TM, Ponomarenko AA, Haas HL, Sergeeva OA, (2005) Differential expression of the homeobox gene Pitx3 in midbrain dopaminergic neurons. European Journal of Neuroscience 22: 1287-1293.
50. Mirnics K, Pevsner J, (2004) Progress in the use of microarray technology to study the neurobiology of disease. Nature Neuroscience 7: 434-439.
51. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, et al. (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141: 1146-1158.
52. Sutherland GT, Matigian NA, Chalk AM, Anderson MJ, Silburn PA, et al. (2009) A cross-study transcriptional analysis of Parkinson's disease. PLoS ONE 4: e4955.